. Scope Venue Agenda Deadlines Organisers Sponsors  
Final Programme
Monday 6th December
15:00 - 17:00
Registration
Exhibition set-up
Poster presentations set-up
SESSION I - Opening Lectures
17:00 - 17:15 Welcome note and official addresses
17:15 - 18:00 Opening Lecture 1: Quantitative Proteomics: Current Status, Limitations and New Directions
Ruedi Aebersold, Institute for Systems Biology, Seattle, WA, USA
18:00 - 18:45 Opening Lecture 2: Proteomics-driven drug discovery in Alzheimer's disease
Adele Rowley, Cellzome Ltd, Cambridge, United Kingdom
18:45 - 19:30 WELCOME RECEPTION
Tuesday 7th December
7:45 - 8:30 Registration / Coffee
SESSION II - Alternative Proteomics Techniques
8:30 - 9:05 Invited Lecture:  High throughput crystallisation of proteins
Karl Harlos, Division of Structural Biology, University of Oxford, UK
9:05 - 9:25 Oral Presentation: Development of AGT-based protein microarrays
Anke Arnold, EPFL, Lausanne, Switzerland
9:25 - 9:45 Oral Presentation: Novel Strategies for Differential Quantitative Analysis of Complex Proteomes
Josef Schwarz, Proteome Sciences plc, Frankfurt, Germany
9:45 - 10:05 Oral Presentation: In vivo biotinylation - a novel proteomic technology for the discovery of accessible targets for selective drug delivery
Jascha-Nikolai Rybak, ETH Zurich, Switzerland
   
10:05 - 10:35 COFFEE BREAK
SESSION III - Profiling Strategies & Protein Interactions
10:35 - 11:10

Invited Lecture: Degradomics: System Wide Analysis of the Human Protease Web
Chris Overall, University of British Columbia, Vancouver, Canada

11:10 - 11:45

Invited Lecture: The ethical dilemma of unauthorized findings
Christoph Rehmann-Sutter, Unit for Ethics in Bioscience, University of Basel, Switzerland

11:45 - 12:05 Oral Presentation: Evaluation of pre-analytical conditions for proteome profiling in human blood using matrix assisted laser desorption ionization-time of flight mass spectrometry
Sven Baumann, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Germany
12:05 - 12:25 Oral Presentation: Strategy for the development of new compounds dedicated to the treatment of infections with herpes viruses resistant to conventional therapies
Anna Greco, CGMC UMR5534, Villeurbanne, France
12:25 - 12:45 Oral Presentation: Laser ablation-inductively coupled plasma-mass spectrometry: a technique for elucidating metal-drug protein interactions
Isam Khalaila, EPFL, Lausanne, Switzerland
12:45 - 13:30 LUNCH BREAK
13:30 - 15:00 POSTER SESSION I & COFFEE
Tutorial Lectures No 1 - 4
13:00 - 13:30 Beckman Coulter Lecture: Automated proteome simplification and selective fractionation based on differential display [Abstract...]
Guillaume Paton, Beckman-Coulter,  Roissy CDG, France
13:30 - 14:00 Shimadzu Biotech Lecture: The application of trap-TOF technologies to structural analysis of pharmaceutical compounds, proteins and proteoglycans [Abstract...]
Roy Edward, Shimadzu Biotech, Manchester, UK
14:00 - 14:30 Ciphergen Biosystems Lecture: Development of a novel multi-biomarker panel for diagnosis of early stage ovarian cancer through the use of Ciphergen’s PatternTrackTM Process [Abstract...] 
Paul Smith, European Director, Ciphergen Biosystems Inc
14:30 - 15:00 Waters Lecture: A New Generation of Mass Spectrometric and UPLC Based Solutions for Protein Identification, Protein Expression Profiling, and Biomarker Discovery [Abstract...]
Alistair Wallace, Waters Corporation, Manchester, UK
   
SESSION IV - Proteomics for Diagnosis
15:10 - 15:45

Invited Lecture: Requirements on Glycomics Research in Molecular Medicine
Jasna Peter-Katalinić, Institute for Medical Physics and Biophysics,
University of Muenster, Germany

15:45 - 16:05

Oral Presentation: Progress in haematology (2000-2004): the role of proteomics
Jean-Daniel Tissot, Service régional de transfusion sanguine, Lausanne, Switzerland

16:05 - 16:25 Oral Presentation: Determination of Carbohydrate-Deficient Transferrin in Human Serum: Development and Application of a Robust Capillary Electrophoresis Assay
Wolfgang Thormann, Department of Clinical Pharmacology, University of Bern, Switzerland
16:25 - 16:45 Oral Presentation: Candida albicans in the sight point: new weapons to manage the diagnosis of systemic candidiasis
Concha Gil, Facultad Farmacia, Universidad Complutense de Madrid, Spain
16:45 - 17:05 Oral Presentation: Identification of four potential biomarkers for the early diagnosis of stroke
Laure Allard, Biomedical Proteomics Research Group, Geneva, Switzerland
17:05 - 17:25 Oral Presentation: Mass Spectrometry based Analytical Tools for the Molecular Characterization of Human High Density Plasma Lipoproteins
Manfred Heller, Department of Clinical Research, University of Bern, Switzerland
   
17:30 - 18:15 SPS General Council Meeting
   
20:00 GALA DINNER
Kornhaus K e l l e r, Kornhausplatz 18, Bern
Wednesday 8th December
SESSION V - Bioinformatics & Data integration
8:30 - 9:05 Invited Lecture: Integration of proteomics data for systems oriented biological reasoning with a view to target/biomarker discovery, prioritisation and validation
Athula Herath, Oxford Glycosciences, UK / Nestle Research Centre, Switzerland
9:05 - 9:25 Oral Presentation: Comparative proteomics—towards a systems view of plastid differentiation and functions
Torsten Kleffmann, ETH Zuerich, Switzerland
9:25 - 9:45 Oral Presentation: Exploring the profiles and structural implications of K-ras mutations in the NCI-60 panel of cell lines and samples from 500 patients enrolled in an NIH-funded peptide vaccine trial
Djamel Medjahed, NCI/SAIC, Frederick, USA
9:45 - 10:05 Oral Presentation: Prediction of metal binding proteins based on secondary structure information using a fuzzy logic-based method
Huseyin Seker, De Montfort University, Leicester, United Kingdom
10:05 - 10:30 COFFEE BREAK
SESSION VI - Protein profiling
10:30 - 11:05

Invited Lecture: Protein Profiling of Patient Samples
Denis F. Hochstrasser, Clinical Proteomics Group, Geneva University Hospital, Switzerland

11:05 - 11:25

Oral Presentation: Mass Spectrometric Proteome Analyses of Biomaterials from Patients Suffering from Rheumatoid Arthritis, and Comparison to Osteoarthritis: An approach to Discover Biomarker Proteins in Body Fluids and Tissues
Michael Glocker, Proteome Center Rostock, Germany

 
11:30 - 12:30 Round table discussion
Biomarkers Discovery & Clinical Applications of Proteomics: Past, Present and Future issues
   
12:30 - 13:30 LUNCH BREAK
13:30 - 15:00 POSTER SESSION II & COFFEE
Tutorial Lectures No 5 - 8
13:00 - 13:30 Bio-Rad Lecture: Tools for Sample Preparation and Fractionation in 2D Electrophoresis  [Abstract...]
Anton Posch, Grafing, Germany
13:30 - 14:00 GeneBio Lecture: Phenyx: Achieving increased pertinence in protein identification and characterization  [Abstract...]
Pierre-Alain Binz & Alexandre Masselot, GeneBio, Geneva, Switzerland
14:00 - 14:30 Tecan Lecture: High Performance In-Gel Digestion of Proteins: Sensitive and Robust Sample Preparation for MALDI-TOF MS and LC MS Using a Novel Type of Microplates  [Abstract...]
Roland Durner, Tecan Switzerland AG, Maennedorf, Switzerland
14:30 - 15:00 Applied Biosystems Lecture: Stable Isotope labeling for profiling, identification and quantitation of putative biomarkers
Martin Hornshaw, Proteomics Marketing Manager - Europe, Applied Biosystems
   
SESSION VII - Proteomics for Prevention
15:10 - 15:45 Invited Lecture: The diversity of the molecular allergen repertoire: the "Allergome"
Gabriel Peltre, ESPCI, LECA, Allergie et Environnement, Paris, France
15:45 - 16:20 Invited Lecture: Proteomics in the context of nutrition and health
Martin Kussmann, Nestlé Research Centre, Lausanne, Switzerland
   Proteomics imaging
16:20 - 16:40

Oral Presentation: Proteome imaging: a prerequisite for any MS-related proteomic study?
Ron Appel, Swiss Institute of Bioinformatics, Genève 4, Switzerland

16:40 - 17:00 Oral Presentation: Message from the tissues: Peptidomics analysis of plasma samples from healthy volunteers after oral glucose challenge
Harald Tammen, BioVisioN AG, Hannover, Germany
17:00 - 17:20 Oral Presentation: Laser Imaging - Mass Spectrometry: a new Platform Technology for Pharmaceutical Discovery
Hélène Meistermann, F. Hoffmann-La Roche Ltd, Basel, Switzerland
17:20 - 17:30 Closing remarks
17:30 FAREWELL COCKTAIL

 




No Keywords

Congress management:

 

Powered by   v 3.5.3  © 2002-2004 All rights reserved